Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection:: Modulation of IL-10 and Ig production after intravenous Ig infusion

被引:50
作者
Müller, F
Aukrust, P
Nordoy, I
Froland, SS
机构
[1] Univ Oslo, Rikshosp, Sect Clin Immunol & Infect Dis, Dept Med A, N-0027 Oslo, Norway
[2] Univ Oslo, Natl Hosp, Internal Med Res Inst, Rikshosp, Oslo, Norway
关键词
D O I
10.1182/blood.V92.10.3721.422k11_3721_3729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms leading to polyclonal hypergammaglobulinemia in patients with human immunodeficiency virus (HIV) infection are not well understood. In light of the important role of interleukin-10 (IL-10) and the interaction between CD40 and CD40 ligand in the normal regulation of B-lymphocyte function and Ig production, we examined these parameters in 24 HIV-infected patients. Both plasma IL-10 levels and the percentage of CD4(+) and CD8(+) lymphocytes expressing CD40 ligand were significantly higher in the patients than in the 10 blood donor controls. Serum IgG correlated positively with circulating IL-10 levels and the percentage of CD4(+) lymphocytes expressing CD40 ligand. Furthermore, a single bolus infusion of intravenous Ig (0.4 g/kg) in 8 HIV-infected patients caused a further increase in IL-10 levels in plasma and an increase in both IL-10 and IgG production in peripheral blood mononuclear cell cultures. In another patient group (Wegener's granulomatosis) receiving a single bolus infusion of intravenous Ig, a similar increase in plasma IL-10 levels was found, suggesting that this may be a general effect of intravenous Ig. In patients with HIV infection, our data suggest that a vicious cycle may be operative where high endogenous Ig levels may enhance IL-10 production that, in turn, leads to higher Ig production. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:3721 / 3729
页数:9
相关论文
共 68 条
[1]   ANTI-CYTOKINE NATURE OF NATURAL HUMAN-IMMUNOGLOBULIN - ONE POSSIBLE MECHANISM OF THE CLINICAL EFFECT OF INTRAVENOUS IMMUNOGLOBULIN THERAPY [J].
ABE, Y ;
HORIUCHI, A ;
MIYAKE, M ;
KIMURA, S .
IMMUNOLOGICAL REVIEWS, 1994, 139 :5-19
[2]  
AKRIDGE RE, 1994, J IMMUNOL, V153, P5782
[3]  
AMADORI A, 1989, J IMMUNOL, V143, P2146
[4]  
AMADORI A, 1991, J IMMUNOL, V146, P57
[5]  
AMEGLIO E, 1994, J BIOL REG HOMEOS AG, V8, P48
[6]  
AMEGLIO F, 1994, CLIN EXP IMMUNOL, V95, P455, DOI 10.1111/j.1365-2249.1994.tb07018.x
[7]  
AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447
[8]   Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes macrophages [J].
Andersson, J ;
SkansenSaphir, U ;
Sparrelid, E ;
Andersson, U .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 :10-20
[9]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[10]  
AUCOUTURIER P, 1986, CLIN EXP IMMUNOL, V63, P234